Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Magellan Health stock | 78.25

Own Magellan Health stock in just a few minutes.

Posted

Fact checked

Magellan Health, Inc is a healthcare plans business based in the US. Magellan Health shares (MGLN) are listed on the NASDAQ and all prices are listed in US Dollars. Magellan Health employs 10,100 staff and has a trailing 12-month revenue of around USD$7.1 billion.

How to buy shares in Magellan Health

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Magellan Health Find the stock by name or ticker symbol: MGLN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Magellan Health reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$78.25, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Magellan Health, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Magellan Health. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Magellan Health's share price?

Since the stock market crash in March caused by coronavirus, Magellan Health's share price has had significant positive movement.

Its last market close was USD$78.25, which is 6.77% up on its pre-crash value of USD$72.95 and 155.72% up on the lowest point reached during the March crash when the shares fell as low as USD$30.6.

If you had bought USD$1,000 worth of Magellan Health shares at the start of February 2020, those shares would have been worth USD$498.57 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,091.59.

Magellan Health share price

Use our graph to track the performance of MGLN stocks over time.

Magellan Health shares at a glance

Information last updated 2020-10-16.
Latest market closeUSD$78.25
52-week rangeUSD$30.6 - USD$80.18
50-day moving average USD$75.536
200-day moving average USD$69.5439
Wall St. target priceUSD$89.67
PE ratio 18.8966
Dividend yield N/A (0%)
Earnings per share (TTM) USD$5.766

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Tastyworks
$0
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Magellan Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Magellan Health price performance over time

Historical closes compared with the close of $78.25 from 2020-10-16

1 week (2020-10-13) -0.17%
1 month (2020-09-18) 4.99%
3 months (2020-07-20) 5.27%
6 months (2020-04-20) 51.56%
1 year (2019-10-18) 25.40%
2 years (2018-10-19) 17.18%
3 years (2017-10-20) -10.01%
5 years (2015-10-20) 56.28%

Is Magellan Health under- or over-valued?

Valuing Magellan Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Magellan Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Magellan Health's P/E ratio

Magellan Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Magellan Health shares trade at around 19x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Magellan Health's PEG ratio

Magellan Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.93. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Magellan Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Magellan Health's EBITDA

Magellan Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$197.1 million.

The EBITDA is a measure of a Magellan Health's overall financial performance and is widely used to measure a its profitability.

Magellan Health financials

Revenue TTM USD$7.1 billion
Operating margin TTM 1.67%
Gross profit TTM USD$227.2 million
Return on assets TTM 2.31%
Return on equity TTM 7.15%
Profit margin 2.02%
Book value $60.962
Market capitalisation USD$2 billion

TTM: trailing 12 months

Shorting Magellan Health shares

There are currently 353,904 Magellan Health shares held short by investors – that's known as Magellan Health's "short interest". This figure is 7.2% down from 381,326 last month.

There are a few different ways that this level of interest in shorting Magellan Health shares can be evaluated.

Magellan Health's "short interest ratio" (SIR)

Magellan Health's "short interest ratio" (SIR) is the quantity of Magellan Health shares currently shorted divided by the average quantity of Magellan Health shares traded daily (recently around 139332.28346457). Magellan Health's SIR currently stands at 2.54. In other words for every 100,000 Magellan Health shares traded daily on the market, roughly 2540 shares are currently held short.

However Magellan Health's short interest can also be evaluated against the total number of Magellan Health shares, or, against the total number of tradable Magellan Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Magellan Health's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Magellan Health shares in existence, roughly 10 shares are currently held short) or 0.0184% of the tradable shares (for every 100,000 tradable Magellan Health shares, roughly 18 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Magellan Health.

Find out more about how you can short Magellan Health stock.

Magellan Health share dividends

We're not expecting Magellan Health to pay a dividend over the next 12 months.

Magellan Health share price volatility

Over the last 12 months, Magellan Health's shares have ranged in value from as little as $30.6 up to $80.18. A popular way to gauge a stock's volatility is its "beta".

MGLN.US volatility(beta: 1.16)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Magellan Health's is 1.1561. This would suggest that Magellan Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Magellan Health overview

Magellan Health, Inc. provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. It offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is based in Phoenix, Arizona.

Frequently asked questions

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site